MANNKIND CORP Forward Contract Indexed to Issuer's Equity, Shares
MANNKIND CORP (MNKD) reported Forward Contract Indexed to Issuer's Equity, Shares of 350.00 million shares for the 1-month period ending 2012-12-31, per its 10-K filed 2015-03-02.
Discontinued › Notes › Other Liabilities
us-gaap:ForwardContractIndexedToIssuersEquityShares · last filed 2015-03-02
- 2012-12-31: Forward Contract Indexed to Issuer's Equity, Shares 1 month 350.00M shares.
- 2012-12-20: Forward Contract Indexed to Issuer's Equity, Shares 0 month 350.00M shares.
- 2012-05-31: Forward Contract Indexed to Issuer's Equity, Shares 1 month 250.00M shares.
- 2012-05-17: Forward Contract Indexed to Issuer's Equity, Shares 0 month 250.00M shares; Forward Contract Indexed to Issuer's Equity, Shares 250.00M shares; Forward Contract Indexed to Issuer's Equity, Shares 1 month 250.00M shares.
| Period end | Forward Contract Indexed to Issuer's Equity, Shares 0 month | Forward Contract Indexed to Issuer's Equity, Shares | Forward Contract Indexed to Issuer's Equity, Shares 1 month |
|---|---|---|---|
| 2012-12-31 | 350.00M shares 10-K · filed 2015-03-02 | ||
| 2012-12-20 | 350.00M shares 10-K · filed 2014-03-03 | ||
| 2012-05-31 | 250.00M shares 10-K · filed 2014-03-03 | ||
| 2012-05-17 | 250.00M shares 10-K · filed 2014-03-03 | 250.00M shares 10-K · filed 2015-03-02 | 250.00M shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |